Recent findings indicate that the renin–angiotensin–aldosterone system is also involved in the development of CSA-AKI, suggesting a reduced activity of angiotensin-converting enzyme (ACE) and decreased levels of angiotensin II associated with cardiopulmonary bypass [15]. The gene discussed is ACE; the disease is chromosome-type aberration frequency.